Trial Profile
A trial to study analysis of peripheral blood mononuclear cell phenotypes during treatment with fingolimod
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 May 2016
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions; Pharmacodynamics
- 02 May 2016 New trial record
- 21 Apr 2016 Results presented at the 68th Annual Meeting of the American Academy of Neurology